🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Baird raises IBEX stock target, holds rating on AI growth potential

EditorNatashya Angelica
Published 16/09/2024, 15:20
IBEX
-


On Monday, Baird, a financial services firm, increased its price target for IBEX Ltd. (NASDAQ: NASDAQ:IBEX) shares to $23.00, up from the previous target of $20.00. The firm has maintained an Outperform rating on the stock.


The adjustment follows a recent call with IBEX management, after which Baird expressed a positive outlook on the company's potential. According to Baird, industry demand is showing signs of stabilization, highlighted by IBEX's revenue growth in the fourth fiscal quarter.


The firm also noted the company's aspirations to achieve 5-7% revenue growth and 15% EBITDA margins over time, with artificial intelligence playing a significant role in driving these margin expansion opportunities.


Baird finds the valuation of IBEX Ltd. attractive, citing multiples of approximately 8 times the estimated earnings per share (EPS) for calendar year 2025 and 4 to 4.5 times the estimated EBITDA for the same period. The firm points out that, historically, customer care companies are acquired at around 7 to 8 times the next twelve months' (NTM) EBITDA. Applying this metric to IBEX suggests that there could be a 50-55% upside to the current stock price.


The financial services firm's outlook is based on current market conditions and the company's financial projections. IBEX Ltd.'s performance and future valuation will continue to be subject to market trends and the company's operational execution.


In other recent news, IBEX Ltd. has been the focus of several significant developments. The company reported a transformative year with a record increase in EPS to $2.10 and a rise in free cash flow to $27 million. Despite a slight annual revenue decrease to $509 million, IBEX's Q4 revenue indicated a year-over-year increase, suggesting a return to growth.


The company is entering fiscal year 2025 with a positive outlook, expecting revenue between $510 million and $525 million and adjusted EBITDA of $67 million to $69 million.


RBC Capital Markets has raised its price target for IBEX from $18 to $20, maintaining a Sector Perform rating. The adjustment followed IBEX's recent announcement of a return to revenue growth, marking a 1% year-over-year increase in the last quarter. The revised stock price target reflects RBC's confidence in IBEX's strategic direction, which includes a focus on more profitable service areas and the implementation of advanced technologies.


Simultaneously, Baird reaffirmed its Outperform rating for IBEX with a steady price target of $20.00, following the company's strong financial results for the fourth quarter. The firm's analysis highlighted that IBEX's revenue, EBITDA, and EPS for the quarter surpassed Wall Street's expectations.


The positive performance has led to a projection of a 5-10% increase in the stock's value on the next trading day. These recent developments underscore the positive trajectory of IBEX's financial performance.


InvestingPro Insights


Following Baird's positive adjustment of IBEX Ltd.'s price target, an analysis of real-time data from InvestingPro provides additional insights. With a market capitalization of approximately $336.74 million and a price-to-earnings (P/E) ratio of 10.62, IBEX is trading at a low earnings multiple. This aligns with Baird's valuation perspective, as the company's current P/E ratio is attractive relative to its near-term earnings growth potential.


InvestingPro Tips highlight that IBEX management has been actively engaged in share buybacks, which can often be a sign of confidence in the company's future performance. Moreover, the company's strong shareholder yield is noteworthy, as it suggests a commitment to delivering value to investors.


From a performance standpoint, IBEX has seen significant returns, with an 18.34% price total return over the last week and a 43.86% return over the past year, emphasizing the company's robust short-term and annual performance. This data underlines the recent uptick in the company's stock price, further supporting Baird's optimistic outlook.


For readers interested in a deeper dive into IBEX's financial health and future prospects, InvestingPro offers additional tips, including analysis on the company's debt levels, liquidity, and profitability. With 15 more InvestingPro Tips available, investors can gain a comprehensive understanding of the company's position and potential at https://www.investing.com/pro/IBEX.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.